Dr. Oz show discusses DIM for estrogen balance and as the "Bust Butt Fat Supplement". BioResponse DIM® is covered under Patent # 6,534,085 For Weight Loss and Fat Metabolism: Zeligs, MA. May 2, 2012.
The National Cancer Institute (NCI-DCP) has renewed its Clinical Trials Agreement with BioResponse LLC, November 2009.
The Wide World of Health Radio Show (Talk 650 KSTE): Show host Cary Nosler interviews Dr. Michael Zeligs as they explore the amazing possibilities of BioResponse DIM. March 15, 2009.
The National Cancer Institute (NCI-DCP) has renewed its Clinical Trials Agreement with BioResponse LLC, December 2008.
Dr. Irwin C. Jacobs presented "BioResponse DIM Formulation Advances and New Anti-viral Uses" at the Controlled Release Society Meetings, June 2008.
The National Cancer Institute (NCI-DCP) has renewed its Clinical Trials Agreement with BioResponse LLC, November 2007.
Women's Edition June 2007- Article by Jenny Brossard. Women's Edition Magazine, "Out and About", June 2007.
Second Opinion August 2005- Dr. Robert Jay Rowen's Second Opinion Newsletter. Front Page Article, "Redesigned Supplement Fights Breast and Prostate Cancer", August 2005.
Cancer Research UK and BioResponse LLC of Boulder, CO have entered into a Clinical Trials Agreement. BioResponse LLC will provide the study supplement, BioResponse DIM. "Can cabbage compounds help prevent cervical cancer?" November, 2004. |
